BOSTON SCIENTIFIC CORP — Director's Dealing 2022

May 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2022-05-01

Reporting Person: Scanlon Meghan (SVP,Pres,Urology Pelvic Health)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-01	Common Stock	M	2062.0000	$0.0000	Acquired	25067.0000	Direct
2022-05-01	Common Stock	F	606.0000	$42.1100	Disposed	24461.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-01	Deferred Stock Units	$	M	2062.0000	Disposed	2023-05-01	Common Stock (2062.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 1, 2020, the first anniversary of the date of grant.